Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.


We aimed to model whether unsupervised iOAT may be effective in reducing fatal and non–fatal overdose, and estimate the cost per life saved.

Original research | 2022
Overdose, Evidence base, Policy/Regulatory

This was a within-subjects study using data from 2187 Ohio prison residents who engaged with a digital CBT program to address their methamphetamine use.

Original research | 2022
Stimulants, Justice system/law enforcement, Digital health, About PWUD

This study aimed to examine the degree to which race and other identity markers (i.e., gender and type of opioid used) interact and drive the stigmatization of an opioid addiction.

Original research | 2022
Stigma, About PWUD, Equity, Sex/Gender

We examined client and staff perceptions of the relationship between trauma and SUDs, and the integration of trauma-informed care (TIC) and specialist-delivered treatment for PTSD in residential al

Original research | 2022
Mental health, About prescribers, About PWUD, Wrap-around services
Commentary | 2022

This study assessed overall and age-specific time trends in the prevalence of 12-month hallucinogen use in the US general population.

Original research | 2022
Hallucinogens/psychedelics, Youth, About PWUD

To test if opium tincture (OT) was non-inferior to methadone in retaining participants in opioid agonist treatment (OAT).

Original research | 2022
Substitution/OAT, About PWUD

We examined profiles of polysubstance use among younger and older adults involved in the criminal legal system who use opioids, and explored their experiences and motivations related to substance u

Original research | 2022
Youth, Justice system/law enforcement, About PWUD

We examined whether American psychiatrists’ perceptions of four psychoactive drugs differed from those indicated by their schedules.

Original research | 2022
Policy/Regulatory, About prescribers, Stimulants, Hallucinogens/psychedelics

We aimed to determine the ratio of female:male participation in clinical trials for SUDs and describe the reporting of sex-specific outcomes from 2010 to 2019.

Lit review | 2022
Sex/Gender , 2SLGBTQI+
Étude de cas | 2022
l'approvisionnement plus sécuritaire, à propos des prescripteurs, la politique / le cadre de réglementation, les services enveloppants, les obstacles et les facilitateurs, la base de donnés probantes, les services sociaux, la réduction des méfaits
Commentaire | 2022
l'approvisionnement plus sécuritaire, à propos des personnes qui utilisent des drogues, les avantages socials

We estimated the extent to which different dosing strategies would affect risk of relapse over 12 weeks of treatment, separately for BUP-NX and methadone.

Original research | 2022
Substitution/OAT, Outcomes

We examined the validity of a fentanyl test strip (FTS) in detecting fentanyl and its related analogs in water-based illicit drug solutions.

Original research | 2022
Drug checking

To reach individuals who use substances alone, Grenfell Ministries, a not for profit agency in Hamilton Ontario created a phone-based supervision service to target individuals who use substances al

Original research | 2022
Digital health, Overdose, Outcomes

The aim of this review was to identify actions, interventions and treatments that provide an opportunity for a change in identity and support a recovery journey and the implications for HCV care.

Lit review | 2022
Transitions in care/treatment, About PWUD, Social services, Stigma

MOUD treatment was recently mandated in seven Massachusetts jails, but little is known about barriers and facilitators to treatment continuity post-release.

Original research | 2022
Substitution/OAT, Justice system/law enforcement, About prescribers, Barriers and enablers
Original research | 2022
Policy/Regulatory, Chronic pain

Refine Your Search